Advertisement

Pulmonary Diseases

  • James F. Morris

Abstract

The bronchopulmonary system is subject to environmental ravages. Every few seconds, the ambient air and all it contains is inhaled and comes in contact with a surface area equivalent in the adult to the size of a tennis court. Perhaps, we are endowed with one extra lung in anticipation of environmental slings and arrows, natural in earlier days and manmade today. With a normal aging process, the bronchopulmonary system should be adequate for about 90 years of continuous functioning. The lungs initially were thought to be designed only for acting as a fluctuating bellows, which results in the transfer of oxygen and carbon dioxide. Additional pulmonary biochemical and immunologic roles have been discovered, revealing a more active metabolic status.

Keywords

Interstitial Lung Disease Chronic Bronchitis Small Cell Carcinoma Bacterial Pneumonia Ipratropium Bromide 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Macklem PT. Respiratory muscles: the vital pump. Chest 1980; 78: 753–758.PubMedCrossRefGoogle Scholar
  2. 2.
    Luce JM, Culver BH. Respiratory muscle function in health and disease. Chest 1982; 81: 82–90.PubMedCrossRefGoogle Scholar
  3. 3.
    Green GM, Jakab GJ, Low RB, et al. Defense mecha-nisms of the respiratory membrane. Am Rev Respir Dis 1977; 115: 479–514.PubMedGoogle Scholar
  4. 4.
    Pierson DJ, Hudson LD. Evaluation of dyspnea. Geriat-rics 1981; 36: 48–62.Google Scholar
  5. 5.
    Kent S. The aging lung, I: loss of elasticity. Geriatrics 1978; 33: 124–130.PubMedGoogle Scholar
  6. 6.
    Manderly JL. Effect of age on pulmonary structure and function of immature and adult animals and man. Fed Proc 1979; 38: 173–177.Google Scholar
  7. 7.
    Jones RL, Overton TR, Hammerlindl DM, et al. Effects of age on regional residual volume. J Appl Physiol 1978; 44: 195–199.PubMedGoogle Scholar
  8. 8.
    Knudson RJ, Clark DF, Dennedy TC, et al. Effect of aging alone on mechanical properties of the normal adult lung. J Appl Physiol 1977; 43: 1054–1062.PubMedGoogle Scholar
  9. 9.
    Dhar S, Shastri SR, Lenoar RA. Aging and the respira-tory system. Med Clin North Am 1976; 60: 1121–1139.PubMedGoogle Scholar
  10. 10.
    Kent S. Decline of pulmonary function. Geriatrics 1978; 33: 100–111.PubMedGoogle Scholar
  11. 11.
    Morris JF. Spirometry in the evaluation of pulmonary function. West J Med 1976; 125: 110–118.PubMedGoogle Scholar
  12. 12.
    Morris JF, Koski A, Johnson LC. Spirometric standards for healthy nonsmoking adults. Am Rev Respir Dis 1971; 103: 57–67.PubMedGoogle Scholar
  13. 13.
    Morris J, Koski A, Temple WP, et al. Fifteen-year interval spirmetric evaluation of the Oregon predictive equations. Chest 1988; 92: 123–127.CrossRefGoogle Scholar
  14. 14.
    Morris JF, Temple WP. Spirometric “lung age” estima-tion for motivating smoking cessation. Prev Med 1985; 14: 655–662.PubMedCrossRefGoogle Scholar
  15. 15.
    Gardner RM, et al. Snowbird workshop on standardi-zation of spirometry: a statement by the American Thoracic Society. Am Rev Respir Dis 1979; 119: 831–838.Google Scholar
  16. 16.
    Sorbini C, Grassi V, Salmas F, et al. Arterial oxygen tension is relation to age in healthy subjects. Respiration 1968; 25: 3–10.PubMedCrossRefGoogle Scholar
  17. 17.
    Ward RJ, Tolas AG, Benveniste RJ, et al. Effect of posture on normal arterial blood gas tensions in the aged. Geriatrics 1966; 21: 139–143.Google Scholar
  18. 18.
    Berger AJ, Mitchell RA, Severinghaus JW. Regulation of respiration. N Engl J Med 1977;297:92–97, 134–143, 194–206.Google Scholar
  19. 19.
    Block AJ. Is snoring a risk factor? Chest 1981; 80: 525.PubMedCrossRefGoogle Scholar
  20. 20.
    Burki NK. Dyspnea. Lung 1987; 165: 269–277.PubMedCrossRefGoogle Scholar
  21. 21.
    Mahler DA. Dyspnea: diagnosis and management. Clin Chest Med 1987; 8: 215–230.PubMedGoogle Scholar
  22. 22.
    Wasserman K, Whipp BJ. Exercise physiology in health and disease. Am Rev Respir Dis 1975; 112: 219–249.PubMedGoogle Scholar
  23. 23.
    Astrand PO. Human physical fitness with special refer-ence to sex and age. Physiol Rev 1956; 36: 307–335.PubMedGoogle Scholar
  24. 24.
    deVries HA. Physiological effects of an exercise training regimen upon men aged 52 to 88. J Gerontol 1970; 25: 325–336.CrossRefGoogle Scholar
  25. 25.
    deVries HA. Tips on prescribing exercise regimens for your older patients. Geriatrics 1979; 34: 75–81.PubMedGoogle Scholar
  26. 26.
    Belman MJ, Mittman C. Ventilatory muscle training improves exercise capacity in chronic obstructive pul-monary disease patients. Am Rev Respir Dis 1980; 121: 273–280.PubMedGoogle Scholar
  27. 27.
    Heath GW, Hagberg JM, Ehsani AA, et al. A physiologi-cal comparison of young and older endurance athletes. J Appl Physiol 1981; 51: 634–640.PubMedGoogle Scholar
  28. 28.
    Oregon Thoracic Society. Chronic Obstructive Pul-monary Disease. 5th ed. New York: American Lung Association; 1981.Google Scholar
  29. 29.
    Shim C, Williams MH Jr. The adequacy of inhalation from canister nebulizers. Am J Med 1980; 69: 891–894.PubMedCrossRefGoogle Scholar
  30. 30.
    Tashkin DP, Ashutosh K, Bleeker, ER et al. Comparison of the anticholinergic bronchodilator ipratropium bro-mide with metaproterenol in chronic obstructive pul-monary disease. Am J Med 1986; 81 (suppl 5A): 81–90.PubMedCrossRefGoogle Scholar
  31. 31.
    Ledoux EJ, Morris JF, Temple WP, et al. Spirometric evaluation of standard and double dose ipratropium bromide and inhaled metaproterenol in patients with chronic obstructive pulmonary disease. Chest 1989; 95: 1013–1016.PubMedCrossRefGoogle Scholar
  32. 32.
    Sahn SA. Corticosteroids in chronic bronchitis and pulmonary emphysema. Chest 1978; 73: 389–396.PubMedCrossRefGoogle Scholar
  33. 33.
    Wynne JW, Block AJ, Hemenway J, et al. Disordered breathing and oxygen desaturation during sleep in pa-tients with chronic obstructive lung disease (COLD). Am J Med 1979; 66: 573–579.PubMedCrossRefGoogle Scholar
  34. 34.
    Nocturnal Oxygen Therapy Trial Group. Continuous or nocturnal oxygen therapy in hyperemic chronic ob-structive lung disease. Ann Intern Med 1980; 93: 391–398.Google Scholar
  35. 35.
    Keogh BA, Crystal RG. Pulmonary function testing in interstitial pulmonary disease. Chest 1980; 78: 856–865.PubMedCrossRefGoogle Scholar
  36. 36.
    Crystal RG, Gadek JE, Ferrans VJ, et al. Interstitial lung disease: current concepts of pathogenesis, staging and therapy. Am J Med 1981; 70: 542–568.PubMedCrossRefGoogle Scholar
  37. 37.
    Nicotra MB, Rivera M, Awe R. Antibiotic therapy of acute exacerbations of chronic bronchitis. Ann Intern Med 1982; 97: 18–21.PubMedGoogle Scholar
  38. 38.
    Phair JP, Kauffman CA, Bjornson A, et al. Host de-fenses in the aged: evaluation of components of the inflammatory and immune responses. J Infect Dis 1978; 138: 67–73.PubMedCrossRefGoogle Scholar
  39. 39.
    Haas H, Morris JF, Samson S, et al. Bacterial flora of the respiratory tract in chronic bronchitis: comparison of transtracheal, fiberbronchoscopic, and oropharyngeal sampling methods. Am Rev Respir Dis 1977; 116: 41–47.Google Scholar
  40. 40.
    Haas H, Morris J, Samson S. Effect of oral penicillin on pneumococcal carriage in elderly men with chronic bronchitis. Clin Ther 1986; 8: 301–308.PubMedGoogle Scholar
  41. 41.
    Sims RV, Steinmann WC, McConville JH, et al. The clinical effectiveness of pneumococcal vaccine in the elderly. Ann Intern Med 1988; 108: 653–657.PubMedGoogle Scholar
  42. 42.
    Wynne JW, Reynolds JC, Hood IC, et al. Steroid therapy for pneumonitis induced in rabbits by aspiration of foodstuff. Anesthesiology 1977; 87: 466–474.Google Scholar
  43. 43.
    Wynne JW, Modell JH. Respiratory aspiration of stom-ach contents. Ann Intern Med 1977; 87: 466–474.PubMedGoogle Scholar
  44. 44.
    Williams GO. Vaccines in older patients, combating the risk of mortality. Geriatrics 1980; 35: 55–64.PubMedGoogle Scholar
  45. 45.
    Dolin R, Reichman RC, Madore HP, et al. A controlled trail of amantadine and rimantadine in the prophylaxis of influenza A infection. N Engl J Med 1982; 307: 580–584.PubMedCrossRefGoogle Scholar
  46. 46.
    VanVoris LP, Betts RF, et al. Successful treatment of naturally occurring influenza A/USSR/77 H1N1. JAMA 1981; 245: 1128–1131.CrossRefGoogle Scholar
  47. 47.
    Thompson NJ, Glassroth JL, Snider DE, et al. The booster phenomenon in serial tuberculin testing. Am Rev Respir Dis 1979; 119: 587–597.PubMedGoogle Scholar
  48. 48.
    Stead WW. The pathogenesis of pulmonary tuberculosis among older persons. Am Rev Respir Dis 1965; 91: 811–822.PubMedGoogle Scholar
  49. 49.
    Miller WT, McGregor RR. Tuberculosis: frequency of unusual radiographic findings. AJR 1978; 130: 867–875.PubMedCrossRefGoogle Scholar
  50. 50.
    Khan MA, Kovnat DM, Bachus F, et al. Clinical and roentgenographic spectrum of pulmonary tuberculosis in the adult. Am J Med 1977; 62: 31–38.PubMedCrossRefGoogle Scholar
  51. 51.
    American Thoracic Society. Treatment of tuberculosis and tuberculosis infection in adults and children. Am Rev Respir Dis 1986; 134: 355–363.Google Scholar
  52. 52.
    Farer LS. Chemoprophylaxis. Am Rev Respir Dis 1982; 125 (p2): 102–07.PubMedGoogle Scholar
  53. 53.
    Matthay RA, Blames JR. Lung Cancer: a persistent challenge. Geriatrics 1982; 37: 109–131.PubMedGoogle Scholar
  54. 54.
    Zavala DC. Diagnostic fiberoptic bronchoscopy: tech-niques and results of biopsy in 600 patients. Chest 1975; 68: 12–19.PubMedCrossRefGoogle Scholar
  55. 55.
    Zavala DC, Schoell JE. Ultrathin needle aspiration of the lung in infectious and malignant disease. Am Rev Respir Dis 1981; 123: 125–131.PubMedGoogle Scholar
  56. 56.
    Bruya T, Morris JF, Barker AF. Bronchoscopy and bone marrow examinations: an efficient strategy to establish the diagnosis of small cell carcinoma of the lung. Chest 1981; 79: 423–426.PubMedCrossRefGoogle Scholar
  57. 57.
    Ali MK, Mountain CF, Ewer MS, et al. Predicting loss of pulmonary function after resection for bronchgenic car-cinoma. Chest 1980; 77: 337–342.PubMedCrossRefGoogle Scholar
  58. 58.
    McNeil BJ, Weichselbaum R, Parker SG. Fallacy of the fiv-year survival in lung cancer. N Engl J Med 1978: 1397–1401.Google Scholar
  59. 59.
    Peterson BA, Kennedy BJ. Aging and cancer manage-ment, I: clinical observations. CA 1979; 29: 322–332.PubMedGoogle Scholar
  60. 60.
    Coy P, Dennelly GM. The role of curative radiotherapy in the treatment of lung cancer. Cancer1980, 45: 698–702.PubMedCrossRefGoogle Scholar
  61. 61.
    Spiro SG. The management of lung cancer: Lung 1982; 160: 141–155.PubMedCrossRefGoogle Scholar
  62. 62.
    Greco FA, Richardson RL, Snell JD, et al. Small cell lung cancer: complete remission and survival. Am J Med 1979; 66: 625–630.PubMedCrossRefGoogle Scholar
  63. 63.
    Bell WR, Simon TL. Current status of pulmonary throm-boembolic disease: pathophysiology, diagnosis, pre-vention, and treatment. Am Heart J 103: 239–262.Google Scholar
  64. 64.
    Freiman DG, Suyemoto J, Wessler S. Frequency of pulmonary embolism in man. N Engl J Med 1965; 272: 1278–1280.PubMedCrossRefGoogle Scholar
  65. 65.
    Hull R, Hirsh J, Sackett DL, et al. Cost effectiveness of clinical diagnosis, venography, and noninvasive testing in patients with symptomatic deep vein thrombosis. N Engl J Med 1981; 304: 1561–1567.PubMedCrossRefGoogle Scholar
  66. 66.
    Hull RD, Hirsh J, Carter CJ, et al. Diagnostic efficacy of impedance plethysomography for clinically suspected deep vein thrombosis: a randomnized trial. Ann Intern Med 1985; 102: 21–28.PubMedGoogle Scholar
  67. 67.
    Lensing, AWA, Prandoni, P, Brandjes, D, et al: Detec-tion of deep-vein thrombosis by real-time B-mode ultra-sonography. N Engl J Med 1989; 320: 342–345.PubMedCrossRefGoogle Scholar
  68. 68.
    Hull R, Delmore T, Carter C, et al. Adjusted sub-cutaneous heparin versus warfarin sodium in the long-term treatment of venous thrombosis. N Engl J Med 1982; 306: 189–194.PubMedCrossRefGoogle Scholar
  69. 69.
    Marder VJ, Sherry S. Thrombolytic therapy: current status. N Engl J Med 1988; 318: 1585–1595.PubMedCrossRefGoogle Scholar
  70. 70.
    Kanter B, Moser KM. The Greenfield vena cava filter. Chest 1988; 93: 170–175.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1990

Authors and Affiliations

  • James F. Morris

There are no affiliations available

Personalised recommendations